ADHD (Methylphenidate, Dexamfetamine, Atomoxetine and Lisdexamphetamine)
(Methylphenidate, Dexamfetamine, Atomoxetine and Lisdexamphetamine)
Shared care guideline for the treatment of Attention Deficit Hyperactivity Disorder in children, young people and adults
Date: 21 October 2015 to 01 January 2099
-
Due for review01 February 2021
-
TypeShared Care Guidelines
-
Clinical support group
-
Brain and mental health
-
Paediatrics
-
-
Drug
-
Traffic LightAmber (SCG)
-
Conditions and indicators
Do you want to add this to your CPD record?
Did you find this page helpful?